News

Tannic Acid Revealed As Possible Cystic Fibrosis Therapy

A new study on Staphylococcus aureus infection and cystic fibrosis (CF) entitled “Counteracting suppression of CFTR and voltage-gated K+ channels by a bacterial pathogenic factor with the natural product tannic acid“ was published on eLife by Yajamana Ramu, part of Dr. Zhe Lu’s group…

CFNZ Holds Fundraising Fashion Show for Awareness Week

Advocates and fundraisers for Cystic Fibrosis continue to develop creative, unique ways to increase awareness of the disease throughout the world and support ongoing clinical research for effective, new therapeutic strategies. Recently, the Cystic Fibrosis Association of New Zealand (CFNZ) joined forces with Ballentynes Fashion Central to organize a fundraising fashion show…

MDL Provides New Prenatal Cystic Fibrosis Testing

A novel Cystic Fibrosis testing technology that features next-generation DNA sequencing platforms has been launched by Medical Diagnostic Laboratories, L.L.C. Certified by the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP), MDL specializes in complex, state-of-the-art, automated DNA-based molecular analyses. The MDL Cystic Fibrosis Core Test is a CFTR gene sequence exam provided…

FDA Advisory Committee Gives Cystic Fibrosis Drug Kalydeco (ivacaftor) Thumbs-Up for Patients Six And Up With R117H Mutation

Vertex Pharmaceuticals Incorporated announced Tuesday that the U.S. Food and Drug Administration’s Pulmonary Allergy Drugs Advisory Committee (PADAC) voted 13-2 to recommend approval of Kalydeco (ivacaftor) in people with cystic fibrosis (CF) ages six and older who have the R117H mutation in the cystic fibrosis transmembrane regulatory (CFTR) gene,…

Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.